Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ovarian Neoplasms
  Free Subscription

Articles published in
Int J Gynaecol Obstet
    September 2025
  1. ASSAF W, Qarawani A, Abboud Y, Shalabna E, et al
    Pathology results of risk-reducing salpingo-oophorectomy in BRCA1/2 carriers and long-term clinical outcomes.
    Int J Gynaecol Obstet. 2025;170:1188-1198.
    >> Share

  2. YANAIHARA N, Tse KY, Lee SJ, Yoo JG, et al
    Immune checkpoint inhibitors in gynecologic oncology: Current status and perspectives.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:166-188.
    >> Share

  3. RENZ M, Friedlander M, Berek JS
    Cancer of the ovary, fallopian tube, and peritoneum: 2025 update.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:6-35.
    >> Share

    July 2025
  4. VO HL, Tran DT, Le LH, Nguyen TTN, et al
    Comparative diagnostic performance of the early-stage ovarian malignancy score versus other risk prediction models in early-stage ovarian cancer: A Vietnamese prospective cohort study.
    Int J Gynaecol Obstet. 2025 Jul 31. doi: 10.1002/ijgo.70383.
    >> Share

  5. MCCLUGGAGE WG
    New histopathological and molecular findings in gynecological cancers.
    Int J Gynaecol Obstet. 2025 Jul 30. doi: 10.1002/ijgo.70283.
    >> Share

  6. GU X, Jiang L, Xu C, Yin J, et al
    Nomogram prediction model based on non-enhanced computed tomography for adnexal torsion: A retrospective multicenter study.
    Int J Gynaecol Obstet. 2025;170:188-199.
    >> Share

    June 2025
  7. CHERUVATHUR JS, Levin G, Ribeiro R, Racovitan F, et al
    Revisiting intraperitoneal chemotherapy for advanced high-grade serous ovarian cancer.
    Int J Gynaecol Obstet. 2025 Jun 26. doi: 10.1002/ijgo.70336.
    >> Share

    April 2025
  8. VARGHESE S, Lim MC, Armbrust R, Pareja R, et al
    Worldwide barriers of optimal surgical care provision in advanced ovarian cancer.
    Int J Gynaecol Obstet. 2025 Apr 25. doi: 10.1002/ijgo.70033.
    >> Share

  9. STRANDELL A, Sundfeldt K, Palsson M, Collins E, et al
    Letter to the editor: FIGO Position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy.
    Int J Gynaecol Obstet. 2025 Apr 23. doi: 10.1002/ijgo.70188.
    >> Share

    February 2025
  10. KANG J, Mei D, Xing X, Cao Y, et al
    Characteristics and prognostic implications of a cohort of 50 Sertoli-Leydig cell tumors at a single center.
    Int J Gynaecol Obstet. 2025;168:613-619.
    >> Share

    January 2025
  11. ALSHWAYYAT S, Abo-Elnour DE, Dabash TY, Alshwayyat TA, et al
    Personalized approach to malignant struma ovarii: Insights from a web-based machine learning tool.
    Int J Gynaecol Obstet. 2025;168:343-352.
    >> Share

    December 2024
  12. OZCIVIT ERKAN IB, Kuru O, Turker Saricoban C, Wardak M, et al
    Unusual synchronous and metachronous association of hematologic neoplasms with gynecologic neoplasms: A case series and literature review.
    Int J Gynaecol Obstet. 2024 Dec 6. doi: 10.1002/ijgo.16075.
    >> Share

    November 2024
  13. BASARIR ZO, Caydere M, Karabulut S, Kotanoglu MS, et al
    The prognostic value of tumor microenvironment in endometrioid type endometrial cancer: Effect of CD44 on oncologic outcome.
    Int J Gynaecol Obstet. 2024 Nov 30. doi: 10.1002/ijgo.16071.
    >> Share

  14. NHA PB, Tu NP, Ha NV, Hien DTT, et al
    Anti-NMDA receptor autoimmune encephalitis associated with ovarian teratoma: A case series and literature review.
    Int J Gynaecol Obstet. 2024 Nov 23. doi: 10.1002/ijgo.16028.
    >> Share

  15. HERAS M, Azcona L, Arencibia O, Minig L, et al
    Oncological safety of fertility preservation treatment in ovarian cancer: A Spanish multicenter study.
    Int J Gynaecol Obstet. 2024 Nov 14. doi: 10.1002/ijgo.16026.
    >> Share

    October 2024
  16. MOR-HADAR D, Wilailak S, Berek J, McNally OM, et al
    FIGO position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy.
    Int J Gynaecol Obstet. 2024 Oct 16. doi: 10.1002/ijgo.15884.
    >> Share

    September 2024
  17. JU UC, Kang WD, Kim SM
    Enhancing the accuracy of preoperative and intraoperative evaluation of malignant ovarian germ cell tumors with a focus on fertility preservation in young women.
    Int J Gynaecol Obstet. 2024 Sep 15. doi: 10.1002/ijgo.15916.
    >> Share

  18. NIE X, Xu T, Cheng W
    Comparative prognosis analysis of ovarian squamous cell carcinoma versus serous carcinoma: Insights from the SEER database.
    Int J Gynaecol Obstet. 2024 Sep 11. doi: 10.1002/ijgo.15899.
    >> Share

    August 2024
  19. LUKAC S, Wenzel R, Schochter F, Friebe-Hoffmann U, et al
    Pregnancy after advanced ovarian cancer with spontaneous uterine rupture in second trimester: A case report and review of the literature.
    Int J Gynaecol Obstet. 2024 Aug 1. doi: 10.1002/ijgo.15837.
    >> Share

    May 2024
  20. BORELLA F, Bertero L, Valabrega G, Fucina S, et al
    Response: Comment on searching for prognostic markers for stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
    Int J Gynaecol Obstet. 2024 May 20. doi: 10.1002/ijgo.15595.
    >> Share

  21. ROECKER ZA, Young MR, Han C
    Rapidly progressing ascites in a pregnancy with a massive fibroid: A case report and review of pseudo-Meigs syndrome.
    Int J Gynaecol Obstet. 2024 May 12. doi: 10.1002/ijgo.15604.
    >> Share

  22. ALIABADI AR, Wilailak S, McNally O, Berek JS, et al
    Contraceptive strategies for reducing the risk of reproductive cancers.
    Int J Gynaecol Obstet. 2024 May 9. doi: 10.1002/ijgo.15567.
    >> Share

  23. BANDHON BZ, Navaneethan S, Patton D
    A case report on the microcystic stromal tumor of the ovary: A rare type of ovarian tumor.
    Int J Gynaecol Obstet. 2024 May 8. doi: 10.1002/ijgo.15580.
    >> Share

  24. TANG Y
    Letter to the editor: Searching for prognostic markers for stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
    Int J Gynaecol Obstet. 2024 May 7. doi: 10.1002/ijgo.15594.
    >> Share

    April 2024
  25. SHIM SH, Yang EJ, Jang EB, Lee S, et al
    Prognostic impact of erythropoietin-stimulating agent use during front-line chemotherapy in patients with ovarian cancer: A Korean multicenter cohort study.
    Int J Gynaecol Obstet. 2024 Apr 29. doi: 10.1002/ijgo.15533.
    >> Share

  26. MIYAMOTO E, Yoshihara M, Iyoshi S, Mogi K, et al
    Factors affecting the long-term prognosis of patients in the AYA generation with epithelial ovarian cancer: A multicenter propensity score matching analysis.
    Int J Gynaecol Obstet. 2024 Apr 12. doi: 10.1002/ijgo.15479.
    >> Share

    March 2024
  27. MUTCH D, Gaffney D, Matias-Guiu X, Fotopoulou C, et al
    Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification.
    Int J Gynaecol Obstet. 2024 Mar 21. doi: 10.1002/ijgo.15478.
    >> Share

  28. SEGOVIA JM, Cantor EA, Vargas HA, Sanabria DE, et al
    Letter to the Editor: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification.
    Int J Gynaecol Obstet. 2024 Mar 21. doi: 10.1002/ijgo.15475.
    >> Share

    January 2024
  29. BRENT SE, McGee J, Vicus D, Kim R, et al
    Rates of genetic consultation in high-grade serous ovarian cancer patients in the era of PARP inhibitor therapy: A population-based study.
    Int J Gynaecol Obstet. 2024 Jan 29. doi: 10.1002/ijgo.15391.
    >> Share

  30. WANG J, Du Y, Kang Y
    Do survivors of borderline ovarian tumors have susceptibility to secondary primary malignancies? A SEER population-based study.
    Int J Gynaecol Obstet. 2024 Jan 11. doi: 10.1002/ijgo.15338.
    >> Share

    December 2023
  31. DEMISSIE L, Birara M, Tolu LB, Sium AF, et al
    Recurrent ovarian cancer in Africa: Rate and associated factors at a gynecologic oncology treatment center in Ethiopia-A cross-sectional study.
    Int J Gynaecol Obstet. 2023 Dec 26. doi: 10.1002/ijgo.15316.
    >> Share

    November 2023
  32. LUO L, Xu N, Liu Y, Zhong S, et al
    Prognostic factors and novel nomograms for overall survival and cancer specific survival of malignant ovarian cancer patients with bone metastasis: A SEER-based study.
    Int J Gynaecol Obstet. 2023 Nov 27. doi: 10.1002/ijgo.15261.
    >> Share

  33. WANG D, Ran X, He Y, Zhu L, et al
    Nomograms for predicting overall survival and cancer-specific survival of endometrioid ovarian carcinoma: A retrospective cohort study from the SEER database.
    Int J Gynaecol Obstet. 2023 Nov 27. doi: 10.1002/ijgo.15263.
    >> Share

  34. GAO C, Han Y, Fan X, Dong H, et al
    A case of unilateral sclerosing stromal tumor of the ovary in a postmenopausal female.
    Int J Gynaecol Obstet. 2023 Nov 12. doi: 10.1002/ijgo.15221.
    >> Share

  35. MA X, Xu L, Ma F, Zhang J, et al
    Whole-tumor apparent diffusion coefficient histogram analysis for preoperative risk stratification in endometrial endometrioid adenocarcinoma.
    Int J Gynaecol Obstet. 2023 Nov 4. doi: 10.1002/ijgo.15226.
    >> Share

  36. RATHAT G, Blay L, Bakenga J, Roggen N, et al
    Scarless preventive surgery.
    Int J Gynaecol Obstet. 2023;163:701-702.
    >> Share

    September 2023
  37. EL HAYEK P, Chlala W, Younes K, Ghaname W, et al
    Severe hemoperitoneum from spontaneous rupture of uterine tumor resembling ovarian sex-cord tumor: A very rare case.
    Int J Gynaecol Obstet. 2023 Sep 25. doi: 10.1002/ijgo.15151.
    >> Share

  38. AYHAN A, Tunc M, Akilli H, Haberal N, et al
    Fertility-sparing approach to malignant ovarian germ cell tumors - Oncologic and obstetric outocome: A retrospective study.
    Int J Gynaecol Obstet. 2023 Sep 22. doi: 10.1002/ijgo.15141.
    >> Share

  39. ANDERSON D, Garcia K, Fang W, Duenas-Garcia O, et al
    Feasibility of opportunistic salpingectomy at the time of a vNOTES hysterectomy: A retrospective cohort.
    Int J Gynaecol Obstet. 2023 Sep 3. doi: 10.1002/ijgo.15085.
    >> Share

    July 2023
  40. BORELLA F, Bertero L, Valabrega G, Fucina S, et al
    Searching for prognostic markers for Stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
    Int J Gynaecol Obstet. 2023 Jul 27. doi: 10.1002/ijgo.15014.
    >> Share

  41. LAVECCHIA M, Dubey A, Jimenez W, Reade CJ, et al
    Intraoperative predictors of appendiceal abnormalities in patients with mucinous ovarian neoplasms.
    Int J Gynaecol Obstet. 2023 Jul 24. doi: 10.1002/ijgo.15008.
    >> Share

    June 2023
  42. MANDATO VD, Torricelli F, Mastrofilippo V, Pellegri C, et al
    Impact of 2 years of COVID-19 pandemic on ovarian cancer treatment in IRCCS-AUSL of Reggio Emilia.
    Int J Gynaecol Obstet. 2023 Jun 26. doi: 10.1002/ijgo.14937.
    >> Share

  43. LOPEZ-GONZALEZ E, Rodriguez-Jimenez A, Gomez-Salgado J, Daza-Manzano C, et al
    Role of tumor volume in endometrial cancer: An imaging analysis and prognosis significance.
    Int J Gynaecol Obstet. 2023 Jun 23. doi: 10.1002/ijgo.14954.
    >> Share

  44. BEREK JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, et al
    FIGO staging of endometrial cancer: 2023.
    Int J Gynaecol Obstet. 2023 Jun 20. doi: 10.1002/ijgo.14923.
    >> Share

    May 2023
  45. EL-TAWAB SS, Kehoe S
    Synchronous ovarian and Bartholin gland carcinoma: Case report and review of literature.
    Int J Gynaecol Obstet. 2023 May 23. doi: 10.1002/ijgo.14880.
    >> Share

  46. VAN STEIN RM, Sikorska K, van der Aa MA, Sonke GS, et al
    Evaluation of external validity of the OVHIPEC-1 trial in a real-world population.
    Int J Gynaecol Obstet. 2023;161:640-648.
    >> Share

    April 2023
  47. FEGHALY I, Kourie H, Moubarak M, Chouery E, et al
    Genetic profile of borderline ovarian tumors in the Lebanese population by whole-exome sequencing.
    Int J Gynaecol Obstet. 2023 Apr 25. doi: 10.1002/ijgo.14805.
    >> Share

    January 2023
  48. PEEYANANJARASSRI K, Nanthamongkolkul K, Jiamset I, Chusook W, et al
    Impact of appendectomy of a grossly normal appendix on the survival outcomes of mucinous ovarian carcinomas in a tertiary hospital.
    Int J Gynaecol Obstet. 2023 Jan 23. doi: 10.1002/ijgo.14689.
    >> Share

    December 2022
  49. LI Q, Zhang X
    Prediction of high-risk factors for ovarian metastasis in patients with endometrial cancer: A large-sample retrospective case-control study.
    Int J Gynaecol Obstet. 2022 Dec 1. doi: 10.1002/ijgo.14606.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016